Tevogen Bio Holdings Inc. granted 8 million shares of restricted stock to its CEO Dr. Ryan Saadi on June 27, 2025, increasing total outstanding shares to 193,693,433. The shares will vest over time based on continued service, with full vesting upon death or disability.